From: Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Clinical outcome | Antihypertensive treatment (n = 1,044) | ACEI/ARB (n = 782) | Non-ACEI/ARB (n = 262) | Unadjusted | Age, sex-adjusted | Multivariable adjusted | |||
---|---|---|---|---|---|---|---|---|---|
OR (95 % CI) | P-value | OR (95 % CI) | P-value | OR (95 % CI) | P-value | ||||
Hospitalization | 540 (51.7) | 389 (49.7) | 151 (57.6) | 1.05 (0.83–1.33) | 0.691 | 1.13 (0.89–1.45) | 0.320 | 1.16 (0.90–1.49) | 0.263 |
Oxygen requirement | 142 (13.6) | 97 (12.4) | 45 (17.2) | 0.87 (0.61–1.24) | 0.445 | 0.96 (0.67–1.37) | 0.802 | 0.96 (0.67–1.38) | 0.813 |
Severe outcome | 76 (7.3) | 49 (6.3) | 27 (10.3) | 0.58 (0.36–0.95) | 0.031 | 0.66 (0.40–1.09) | 0.104 | 0.68 (0.41–1.15) | 0.150 |
ICU admission | 33 (3.2) | 20 (2.6) | 13 (5.0) | 0.57 (0.30–1.09) | 0.084 | 0.60 (0.31–1.16) | 0.127 | 0.61 (0.32–1.18) | 0.139 |
Ventilator care | 21 (2.0) | 12 (1.5) | 9 (3.4) | 0.47 (0.21–1.05) | 0.059 | 0.51 (0.23–1.14) | 0.101 | 0.48 (0.21–1.08) | 0.076 |
Death | 54 (5.2) | 35 (4.5) | 19 (7.3) | 0.69 (0.41–1.16) | 0.161 | 0.78 (0.45–1.33) | 0.358 | 0.75 (0.43–1.30) | 0.302 |